Levo-carnitine (500mg/5ml)

Clinical Pharmacologist's Monograph

⚠️ Prescription Only: This medicine is Schedule H/H1. Do not self-medicate.

1. Clinical Overview

Levo-carnitine (L-carnitine) is a naturally occurring amino acid derivative essential for the transport of long-chain fatty acids into the mitochondrial matrix for beta-oxidation and energy production. The 500mg/5ml oral solution is a concentrated formulation used to treat primary and secondary carnitine deficiencies, and is widely used in India for various metabolic and cardiovascular conditions. It is a conditionally essential nutrient.

OnsetDurationBioavailability
Peak plasma concentrations are typically reached within 2-4 hours after oral administration.The pharmacodynamic effects (e.g., on fatty acid metabolism) correlate with plasma levels, with a duration of several hours. Chronic supplementation aims to maintain steady-state tissue levels.Approximately 15-18% for oral L-carnitine solution, as it undergoes significant first-pass metabolism and competition with dietary carnitine for active transport in the gut.

2. Mechanism of Action

L-carnitine's primary role is to facilitate the transport of activated long-chain fatty acids (as acyl-CoA) across the impermeable inner mitochondrial membrane. It acts as a substrate for carnitine palmitoyltransferase I (CPT I) and II (CPT II), forming acyl-carnitine esters which are shuttled into the mitochondrial matrix. Inside, the acyl group is transferred back to CoA for beta-oxidation, liberating carnitine for reuse. This process is critical for energy production, especially in tissues with high fatty acid demand like cardiac and skeletal muscle.

3. Indications & Uses

  • Primary systemic carnitine deficiency (an autosomal recessive disorder of the OCTN2 transporter)
  • Secondary carnitine deficiency due to: Inborn errors of metabolism (e.g., organic acidurias, mitochondrial disorders), Chronic renal disease on hemodialysis
  • Carnitine deficiency in End-Stage Renal Disease (ESRD) patients undergoing dialysis

4. Dosage & Administration

Adult Dosage: For deficiency states: 1-3 g per day in divided doses (2-3 times daily). Typical dose: 990 mg to 2 g daily. For the 500mg/5ml solution, this translates to 5-20 ml per day in divided doses. For ESRD on dialysis: 10-20 mg/kg dry body weight post-dialysis (IV route common; oral can be used on non-dialysis days).

Administration: Administer orally, preferably with or after meals to improve tolerance and reduce gastrointestinal upset. The solution can be taken directly or diluted in water or juice. Use the measuring cup or syringe provided for accurate dosing. Do not mix with hot beverages. Maintain adequate hydration.

5. Side Effects

Common side effects may include:

  • Nausea
  • Vomiting
  • Abdominal cramps, gastritis
  • Diarrhea (dose-related)
  • Body odor, urine, breath may develop a "fishy" smell due to trimethylamine

6. Drug Interactions

DrugEffectSeverity
Valproic Acid / ValproateValproic acid depletes carnitine levels, leading to deficiency. Levo-carnitine supplementation can prevent or treat valproate-induced hyperammonemia and hepatotoxicity.Major
WarfarinPotential interaction reported; L-carnitine may potentiate the anticoagulant effect of warfarin, increasing INR. Monitor INR closely when starting or stopping carnitine.Moderate
Thyroid Hormones (Levothyroxine)Theoretical interaction as L-carnitine may inhibit the cellular uptake of thyroid hormone. Clinical significance is unclear but monitor thyroid function in patients on both.Minor
AcitretinMay increase the risk of myopathy. Use with caution.Moderate

7. Patient Counselling

  • DO take the medicine as prescribed, with meals if stomach upset occurs.
  • DO use the provided measuring device for accurate dosing.
  • DO inform your doctor if you are on blood thinners like warfarin.
  • DO maintain good hydration.
  • DONT take a double dose to make up for a missed one.
  • DONT stop taking the medicine suddenly without consulting your doctor, especially for deficiency states.
  • DONT share your medicine with others.

8. Toxicology & Storage

Overdose: Symptoms are primarily an extension of side effects: Severe diarrhea, nausea, vomiting, abdominal pain, and body odor. In cases of massive overdose (especially with renal impairment), uremic-like symptoms, myasthenia (severe muscle weakness), and seizures could theoretically occur.

Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep the bottle tightly closed. Do not freeze. Keep out of reach of children. Discard any unused medicine after the expiry date. Do not store the diluted solution for later use.